Genetic Testing Startup Recombine Raises $3.3M | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

New York venture capital firm FirstMark Capital led the round, and other participants included Vast Ventures, Vivek Garipalli, Alexander Saint-Amand, as well as Flatiron Health Co-founders Zach Weinberg and Nat Turner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.